Case Comprehensive Cancer Center

J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to pur...

J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to pur...

The following is a message from the Associate Director for Clinical Research, Mitchell Machtay, MD and Deputy Associate Director for Clinical Research, Mikkael Sekeres, MD. Patients with cancer often turn to clinical trials because their other treatment options are limited. Though there has been a ...

A study led by Nima Sharifi, MD (Hearn, Jama Oncol, 2020) found the adrenal-permissive HSD3B1 allele is associated with earlier castration resistance and shorter overall survival among men with low-volume metastatic prostate cancer. These findings lay the foundation for more personalized and effecti...

Last week, the National Cancer Institute (NCI) advisory meeting was focused on how the NCI is involved in the attack against COVID-19 while maintaining a commitment to cancer research and cancer care. This was the first virtual Joint Meeting (see presentation links) of the NCI Board of Scientific Ad...

The Case Comprehensive Cancer Center has extended deadlines for a variety of open funding opportunities. Pilot project awards range from $10,000 to $180,000 and support innovative and impactful proposals that will generate key data for nationally competitive grants. View all open funding opportunit...

The Case Comprehensive Cancer Center’s Specialized Program of Research Excellence in Gastrointestinal Malignancies (GI SPORE) invites Case Western Reserve University faculty members to submit proposals to be considered for the Career Enhancement Program (CEP) Award and Developmental Research Project...

The following is a message from the Associate Director for Basic Research, Ruth Keri, PhD. I want to thank you all for continuing to attend our weekly Cancer Center Seminar Series as we transitioned to a virtual format three weeks ago. By tuning in via Zoom, we have the opportunity to continue to h...

The Case Comprehensive Cancer Center (Case CCC) is pleased to announce that Lan Zhou, MD, PhD has accepted the role of Scientific Director of the Case Comprehensive Cancer Center (Case CCC) Hematopoietic Biorepository Cell Therapy Shared Resource. Dr. Zhou is an associate professor of pathology and ...

The Case Comprehensive Cancer Center (Case CCC) extends congratulations to members Omar Mian, MD, PhD, Tae Hyun Hwang, PhD and Shilpa Gupta, MD as they were recently awarded a Translational Team Science Award from the Department of Defense totaling $2.3 million. Their project is entitled, "Dissectin...